In patients with stable persistent asthma, can lower doses of inhaled corticosteroid medication control symptoms and maintain optimal pulmonary function as well as high doses?
University of Connecticut, Saint Francis Hospital and Medical Center, Hartford, USA. ejackson2@stfranciscare.org
E A
EA
Jackson
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D019819:Budesonide / Q000008:administration & dosage* / Q000494:pharmacology; D002908:Chronic Disease; D004311:Double-Blind Method; D006801:Humans; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D012129:Respiratory Function Tests; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D019819:Budesonide